DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 103 filers reported holding DYNE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,248,835 | -45.4% | 250,986 | -31.4% | 0.00% | -50.0% |
Q2 2023 | $4,115,531 | +8.9% | 365,825 | +11.5% | 0.00% | 0.0% |
Q1 2023 | $3,779,850 | +3.7% | 328,112 | +4.3% | 0.00% | 0.0% |
Q4 2022 | $3,646,075 | +6.9% | 314,588 | +17.2% | 0.00% | 0.0% |
Q3 2022 | $3,410,000 | +99.6% | 268,525 | +8.0% | 0.00% | +100.0% |
Q2 2022 | $1,708,000 | -3.3% | 248,631 | +35.6% | 0.00% | 0.0% |
Q1 2022 | $1,767,000 | – | 183,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 2,960,046 | $28,535,000 | 16.60% |
MPM ASSET MANAGEMENT LLC | 4,951,303 | $47,731,000 | 16.31% |
Atlas Venture Life Science Advisors, LLC | 8,934,902 | $86,132,000 | 10.89% |
Logos Global Management LP | 2,734,392 | $26,360,000 | 3.42% |
Deep Track Capital, LP | 3,500,000 | $33,740,000 | 2.16% |
Octagon Capital Advisors LP | 525,284 | $5,064,000 | 1.10% |
HighVista Strategies LLC | 168,691 | $1,626,000 | 1.03% |
Monashee Investment Management LLC | 279,704 | $2,696,000 | 0.78% |
COMMODORE CAPITAL LP | 305,125 | $2,941,000 | 0.66% |
RA Capital Management | 2,805,045 | $27,041,000 | 0.59% |